Publication | Closed Access

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

Hematological MalignancyChronic GvhdMedicineMyeloid MalignanciesImmunologyHematologyAdult T-cell Leukemia-lymphomaImmunotherapyOncologyCell TransplantationRabbit Anti-thymocyte-globulin DoseMyeloid Neoplasia